Cover Image

Costs and cost-effectiveness of HIV early infant diagnosis in low- and middle-income countries: a scoping review

Continuing progress in the global pediatric human immunodeficiency virus (HIV) response depends on timely identification and care of infants with HIV. As countries scale-out improvements to HIV early infant diagnosis (EID), economic evaluations are needed to inform program design and implementation....

Full description

Saved in:
Bibliographic Details
Main Authors: Elsbernd, Kira (Author) , Emmert-Fees, Karl M. F. (Author) , Erbe, Amanda (Author) , Ottobrino, Veronica (Author) , Kroidl, Arne (Author) , Bärnighausen, Till (Author) , Geisler, Benjamin P. (Author) , Kohler, Stefan (Author)
Format: Article (Journal)
Language:English
Published: 15 July 2022
In: Infectious diseases of poverty
Year: 2022, Volume: 11, Pages: 1-20
ISSN:2049-9957
DOI:10.1186/s40249-022-01006-7
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s40249-022-01006-7
Get full text
Author Notes:Kira Elsbernd, Karl M.F. Emmert-Fees, Amanda Erbe, Veronica Ottobrino, Arne Kroidl, Till Bärnighausen, Benjamin P. Geisler and Stefan Kohler
Description
Summary:Continuing progress in the global pediatric human immunodeficiency virus (HIV) response depends on timely identification and care of infants with HIV. As countries scale-out improvements to HIV early infant diagnosis (EID), economic evaluations are needed to inform program design and implementation. This scoping review aimed to summarize the available evidence and discuss practical implications of cost and cost-effectiveness analyses of HIV EID.
Item Description:Gesehen am 27.02.2023
Physical Description:Online Resource
ISSN:2049-9957
DOI:10.1186/s40249-022-01006-7

Similar Items